Atlas Trials

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Clinical trial NCT01104298 · TERMINATED

Trial details

NCT number
NCT01104298
Sponsor
Grupo Espanol de Investigacion en Sarcomas
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
2009-11-01
Primary completion
2012-12-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.